post adj ep ahead
cse/con quarterli guidanc adjust rev
bln y/i bln ahead cons/cs adjust
oper incom bln y/i mln cse adjust rev
oper incom ahead est con pharmaci servic
retail/lt adjust rev ahead cons/cs adjust oper incom
health benefit segment adjust rev cse con
oper incom came ahead cse con realiz capit gain
pyd contribut quarter vs along releas also rais
narrow adj ep outlook impli adj
ep outlook vs previous
segment-by-seg result pharmaci servic post adj op inc bln
y/i mln ahead cse/con retail/ltc post adj op inc bln
y/i mln cse/con ss pharmaci sale increas
y/i vs health benefit post adj oi
bln mln ahead cse/con came came bp
better cse continu expect midpoint
quick tidbit present expect aet synergi target
least mln vs approx mln prev compani expect synergi
roughli mln synergi mln chang respect
pbm sell season gross win ytd bln bln
previous continu see medic cost trend rang
outlook updat segment rev outlook mid-point pss rais
mln retail/ltc rais mln maintain hb oi outlook mid-
point pss rais mln retail/ltc lower mln hb
unchang compani expect script fill retail/ltc segment rang
bln vs bln prev expect total pharmaci claim
pss bln vs bln prev
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
total debt capit
caremark corpor caremark pharmaci healthcar
provid unit state provid pharmaci servic
pharmaci benefit manag pbm mail order specialti pharmaci
blue sky scenario predic compani execut
integr aetna gain momentum pbm bueinss
client win better fundament perform sentiment could
drive upsid target price blue sky scenario
grey sky scenario predic client loss
pbm segment addit regulatori shift drug price could
pressur sentiment industri lead depress valuat
 close
compani mention price
 rice jailendra singh certifi respect compani secur individu analyz view express
report accur reflect person view subject compani secur part
compens directli indirectli relat specif recommend view express report
